SEC Form 4 · accession 0000914190-15-000416

NEPHROS INC · NEPH

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Director

Period of report

Sep 9, 2015

Accepted (ET)

Sep 11, 2015 · 4:57 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001196298

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1	Sep 9, 2015	A	97,135	$0.00	A	218,467	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Option (Right to Buy)^F2	$51.40	holding	—	—	—	—	Feb 2, 2016	Common Stock	500	500	D
Stock Option (Right to Buy)^F2	$26.80	holding	—	—	—	—	May 2, 2017	Common Stock	500	500	D
Stock Option (Right to Buy)^F2	$19.00	holding	—	—	—	—	Jan 8, 2020	Common Stock	1,000	1,000	D
Stock Option (Right to Buy)^F2	$0.51	holding	—	—	—	—	Mar 24, 2021	Common Stock	60,000	60,000	D
Stock Option (Right to Buy)^F2	$0.83	holding	—	—	—	—	Feb 16, 2022	Common Stock	10,000	10,000	D
Stock Option (Right to Buy)^F2	$0.71	holding	—	—	—	—	May 23, 2023	Common Stock	10,000	10,000	D
Stock Option (Right to Buy)^F3	$0.46	holding	—	—	—	—	Mar 26, 2024	Common Stock	26,598	26,598	D

F1On September 9, 2015, the Company granted 97,135 shares of restricted stock of the Company (the "Restricted Stock") in respect of the service by Mr. Centella as a member of the Board of Directors of the Company. The Restricted Stock was granted under the Company's 2015 Equity Incentive Plan. The Restricted Stock vests 6 months following the grant date.
F2100% vested.
F3Vests as to 8,866 shares on each of 3/26/14, 3/26/15 and 3/26/16.